A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial

DiscussionIn order to determine the efficacy of α-GalCer-pulsed DC therapy, the present study compares patients with stage II–III NSCLC who underwent complete surgical resection followed by postoperative adjuvant therapy with cisplatin plus vinorelbine, to those who did not receive additional treatment (surgical resection plus postoperative ad juvant chemotherapy only).Trial registrationUMIN000010386 (R000012145). Registered on 1 April 2013.UMIN-CTR is officially recognized as a registration site which satisfies ICMJE criteria.
Source: Trials - Category: Research Source Type: clinical trials